.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Argus Health
Deloitte
Cipla
Julphar
Teva
Chubb
US Department of Justice
Covington
McKinsey
Queensland Health

Generated: November 23, 2017

DrugPatentWatch Database Preview

Claims for Patent: 4,386,104

« Back to Dashboard

Claims for Patent: 4,386,104

Title: Process for the treatment of acne
Abstract:There is disclosed a composition for the treatment of acne, hyperpigmentary dermatoses or skin hyperpigmentation which contains dicarboxylic acids containing 7 to 13 carbon atoms or certain derivatives thereof that contain reducing functional group or a salt thereof. There are also disclosed methods for preparing mercapto derivatives of these dicarboxylic acids.
Inventor(s): Nazzaro-Porro; Marcella (Rome, IT)
Assignee:
Application Number:06/278,720
Patent Claims: 1. A method for the treatment of an individual exhibiting acne which comprises administering to said individual a therapeutically effective amount of an active ingredient in a pharmaceutically acceptable carrier until said condition is reduced or its further development is arrested wherein said active ingredient is at least one dicarboxylic acid containing from 7 to 13 carbon atoms selected from the group consisting of pimelic acid, suberic acid, sebacic acid, azelaic acid, 1,9-nonanedicarboxylic acid, 1.10-decanedicarboxylic acid, and 1,11-undecanedicarboxylic acid or a mono or dimercapto derivative of said acid or a salt thereof.

2. A method as defined in claim 1 wherein said acid is administered orally.

3. A method as defined in claim 1 wherein said acid is administered by injection.

4. A method as defined in claim 1 wherein said acid is administered topically.

5. A method as defined in claim 1 wherein said dicarboxylic acid acid is azelaic acid.

6. A method as defined in claim 1 wherein said dicarboxylic acid is 1,10-decanedicarboxylic acid.
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Moodys
AstraZeneca
QuintilesIMS
Dow
Chinese Patent Office
Fuji
Fish and Richardson
Teva
Julphar
Deloitte

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot